))
An Evolving Treatment Landscape for Inflammatory Disease: Debating Interchangeability, Efficacy, and Safety of Biosimilars
Archived series ("HTTP Redirect" status)
Replaced by: CME Outfitters, LLC Podcasts
When?
This feed was archived on February 27, 2018 12:40 (
Why? HTTP Redirect status. The feed permanently redirected to another series.
What now? If you were subscribed to this series when it was replaced, you will now be subscribed to the replacement series. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.
Manage episode 185446485 series 1331403
Content provided by CME Outfitters. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by CME Outfitters or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
A significant gap exists in awareness and knowledge amongst health care providers on the topic of biosimilars, creating perceived barriers within clinical practices. It’s imperative that clinicians are well-versed on the data surrounding interchangeability, safety, and efficacy of biosimilar agents so that they may confidently select the optimal treatment plan for their patients. In this CME Outfitters On Demand activity, real patient responses are at the center of the conversation, with expert faculty highlight the patients’ concerns while engaging in an evidence-based discussion on a variety of aspects of biosimilars.
50 episodes
Share
